Industry News

Oct 31, 2013
By BioPharm International Editors
WuXi PharmaTech has completed a cell culture capacity expansion, including two 2000 L disposable bioreactors.
Oct 31, 2013
Novartis files Citizen Petition with FDA to maintain naming policy for all biologics to help ensure patient safety.
Oct 28, 2013
By BioPharm International Editors
Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.
Oct 24, 2013
By BioPharm International Editors
SGS Life Science Services opens a Center of Excellence for Biophysical Analysis in the UK.
Oct 23, 2013
By BioPharm International Editors
Beckman Coulter Life Sciences combines its particle characterization business with the Hach Company particle counting business.
Oct 22, 2013
By BioPharm International Editors
Novozymes Biopharma will collaborate with Almac to provide a combined service for drug development applications.
Oct 22, 2013
By BioPharm International Editors
FDA is seeking a permanent injunction against a dietary supplement manufacturer following the company?s repeated distribution of unapproved drugs and adulterated dietary supplements.
Oct 22, 2013
By BioPharm International Editors
FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.
Oct 17, 2013
PhRMA reports 452 new medicines are in development for rare diseases, including genetic disorders, neurological conditions, infectious diseases, and autoimmune disorders.
Oct 17, 2013
By BioPharm International Editors
The US Pharmacopeial Convention posted for public comments on its revisions to the USP Medicare Model Guidelines, which are posted for a 30-day public comment period, beginning Oct. 1, 2013.
native1_300x100
lorem ipsum